AQSZF (Aequus Pharmaceuticals) Interest Expense : $-0.17 Mil (TTM As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Aequus Pharmaceuticals Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Aequus Pharmaceuticals's interest expense for the three months ended in Sep. 2024 was $ -0.05 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.17 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Aequus Pharmaceuticals's Operating Income for the three months ended in Sep. 2024 was $ -0.41 Mil. Aequus Pharmaceuticals's Interest Expense for the three months ended in Sep. 2024 was $ -0.05 Mil. Aequus Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aequus Pharmaceuticals Interest Expense Historical Data

The historical data trend for Aequus Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aequus Pharmaceuticals Interest Expense Chart

Aequus Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.32

-0.41

-0.36

-0.16

-0.11

Aequus Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Interest Expense	Get a 7-Day Free Trial															-0.03	-0.04	-0.04	-0.05	-0.05

Aequus Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.17 Mil.

Aequus Pharmaceuticals (OTCPK:AQSZF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aequus Pharmaceuticals's Interest Expense for the three months ended in Sep. 2024 was $-0.05 Mil. Its Operating Income for the three months ended in Sep. 2024 was $-0.41 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was $0.36 Mil.

Aequus Pharmaceuticals's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Aequus Pharmaceuticals did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Aequus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (OTCPK:AQSZF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

AEQ:Germany AQS:Canada

Address

200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4

Website

https://www.aequuspharma.ca

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.